Biogen Inc. buy Royal Bank of Canada
Start price
13.02.25
/
50%
€130.50
Target price
13.02.26
€215.73
Performance (%)
3.72%
Price
19:54
€135.35
Summary
This prediction is currently active. With a performance of 3.72%, the BUY prediction by Royal_Bank_of_Canada for Biogen Inc. is trending in the right direction. This prediction currently runs until 13.02.26. The prediction end date can be changed by Royal_Bank_of_Canada at any time. Royal_Bank_of_Canada has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Biogen Inc. | 13.832% | 13.832% |
| iShares Core DAX® | 3.900% | 3.645% |
| iShares Nasdaq 100 | 1.567% | 6.505% |
| iShares Nikkei 225® | 0.653% | 8.282% |
| iShares S&P 500 | 1.209% | 4.118% |
Comments by Royal_Bank_of_Canada for this prediction
In the thread Biogen Inc. diskutieren
Biogen Inc. (NASDAQ: BIIB) had its price target lowered by analysts at Royal Bank of Canada from $231.00 to $225.00. They now have an "outperform" rating on the stock.
Ratings data for BIIB provided by MarketBeat